Showing 1641-1650 of 2756 results for "".
- Utah Surgeon's LumipenPro Enlists Archetype to Pursue EU MDR Approvalhttps://modernaesthetics.com/news/utah-surgeons-lumipenpro-enlists-archetype-to-pursue-eu-mdr-approval/2473738/Medtech innovation management consultancy Archetype has been appointed to drive the European Medical Device Regulation (EU MDR) approval process for LumipenPro™, a medical illumination device designed to enhance precision and efficiency during aesthetic surgical procedures where visibility
- Q&A: Optimizing Skincare Routineshttps://modernaesthetics.com/news/qa-optimizing-skincare-routines/2473734/Joelle O’Connor, LE, has worked for some of the most prominent cosmetic practices in the New York and New Jersey area over the past two decades, and currently serves as cosmetic coordinator for Schweiger Dermatology Group in Hackensack, New Jersey. She spoke with Modern Aesthetics about cre
- Merz Aesthetics Releases Findings of Inaugural Global Study Connecting Aesthetics and Self-Affirmationhttps://modernaesthetics.com/news/merz-aesthetics-releases-findings-of-inaugural-global-study-connecting-aesthetics-and-self-affirmation/2473732/Merz Aesthetics launched its inaugural global study in Paris on Wednesday ahead of IMCAS World Congress. The Pillars of Confidence: Global Insights on Aesthetics and Self-Affirmation study, with research support from Ipsos, explores the role confidence plays in daily life and overa
- Allergan Aesthetics Unveiling New AA Signature Program, Immersive Booth at IMCAS World Congress 2025https://modernaesthetics.com/news/allergan-aesthetics-unveiling-new-aa-signature-program-immersive-booth-at-imcas-world-congress-2025/2473731/Allergan Aesthetics, an AbbVie company, is elevating the patient journey with the launch of its news AA Signature Program at the International Master Course of Aging Science (IMCAS) World Congress 2025 in Paris from January 31 through February 1. The new AA Signature Program will
- Galderma Seeks to Address Facial Volume Loss From GLP-1 Medications with Injectable Portfoliohttps://modernaesthetics.com/news/new-datas-promising-results-to-predominant-aesthetic-concerns-for-prescription-weight-loss-medications/2473730/Galderma announced positive first results last week from a trial designed to explore the benefits of Restylane Lyft or Contour in combination with Sculptra in patients with medication-driven weight loss with associated facial volume loss. According to a press release from the manufactur
- Dr. Kay Talks Safeguarding Your Skin from Smoke Damage, Pollution Amid Devastating Los Angeles Wildfireshttps://modernaesthetics.com/news/dr-kay-talks-safeguarding-your-skin-from-smoke-damage-pollution-amid-devastating-los-angeles-wildfires/2473728/It’s been a somber week for residents across California as wildfires left behind mass devastation across multiple neighborhoods in Los Angeles. As firefighters battle to get the wildfires under control, some residents of evacuated areas are beginning to return to what they once called home.
- The Science and Art of Longevity in Aesthetics: A Panel Discussion at Octane Aesthetic Tech Forumhttps://modernaesthetics.com/news/the-science-and-art-of-longevity-in-aesthetics-a-panel-discussion-at-octane-aesthetic-tech-forum/2473727/The 2025 Octane Aesthetic Tech Forum was a two-day meeting filled with innovation, expertise, and a peek into what the future holds for the aesthetic medicine industry. After opening remarks, the forum kicked off with a panel titled “The Science and Art of Longevity in Aesthetics.”&nb
- Illuminate PRP Adds Industry Veteran Redmond as CCOhttps://modernaesthetics.com/news/illuminate-prp-adds-industry-veteran-redmond-as-cco/2473726/Industry veteran Jennifer Redmond, MBA, joined Illuminate PRP as Chief Commercial Officer, the company announced. “Jennifer brings a wealth of experience in sales and marketing within the aesthetics and pharmaceutical industries, along with strong leadership and a commitment to dr
- New Data Reveals GLP-1 Medications Impact on Medical Aesthetics Growthhttps://modernaesthetics.com/news/new-data-reveals-glp-1-medications-impact-on-medical-aesthetics-growth/2473724/Guidepoint Qsight revealed new insights Thursday on the state of the $17.5 billion medical aesthetics industry, which was up 2% in 2024. The findings highlight how the integration of glucagon-like peptide-1 (GLP-1) medications for weight loss is reshaping the aesthetics market. GLP
- Elevai Skincare Inc. Acquired by Bio-Aesthetics Company Carmellhttps://modernaesthetics.com/news/elevai-skincare-inc-acquired-by-bio-aesthetics-company-carmell/2473723/Carmell Corporation, a bio-aesthetics company focused on skin and hair health, announced in a press release that it entered into a definitive purchase agreement with PMGC Holdings Inc. (formerly Elevai Labs Inc.) and its wholly owned subsidiary, Elevai Skincare Inc., to acquire the assets related